Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Journal of Thoracic Disease, 10, S33, S. S3961-S3964
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2018
- Ereignis
-
Veröffentlichung
- (wer)
-
AME Publishing Company
- (wann)
-
2018
- Urheber
- DOI
-
10.21037/jtd.2018.09.81
- URN
-
urn:nbn:de:bvb:384-opus4-1023291
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:48 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Smolle, Elisabeth
- Pichler, Martin
- Universität Augsburg
- AME Publishing Company
Entstanden
- 2018
Ähnliche Objekte (12)
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Best of ASCO 2022: bladder cancer
Inflammation, phagocytosis and cancer: another step in the CD47 act
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
Involvement of the long noncoding RNA NEAT1 in carcinogenesis
The role of microRNAs in breast cancer stem cells
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
The implications of the long non-coding RNA NEAT1 in non-cancerous diseases
The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Best of ASCO 2022: bladder cancer
Inflammation, phagocytosis and cancer: another step in the CD47 act
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
Involvement of the long noncoding RNA NEAT1 in carcinogenesis
The role of microRNAs in breast cancer stem cells
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
The implications of the long non-coding RNA NEAT1 in non-cancerous diseases
The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Best of ASCO 2022: bladder cancer
Inflammation, phagocytosis and cancer: another step in the CD47 act
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
Involvement of the long noncoding RNA NEAT1 in carcinogenesis
The role of microRNAs in breast cancer stem cells
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
The implications of the long non-coding RNA NEAT1 in non-cancerous diseases